<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01467570</url>
  </required_header>
  <id_info>
    <org_study_id>KB/191/2008</org_study_id>
    <nct_id>NCT01467570</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute Gastroenteritis</brief_title>
  <official_title>Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute Gastroenteritis: Randomized, Double-Blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is generally recommended that oral rehydration should be used as first-line therapy to
      treat or prevent dehydration in children with acute gastroenteritis (AGE). Refusal to drink
      regular Oral Rehydration Solution (ORS) interfere with compliance with the recommended
      treatment.

      The objective of this study is to compare the tolerance, acceptance, efficacy and safety of a
      new ORS (Hipp ORS 200 Apple) of improved palatability with regular ORS recommended by ESPGHAN
      in children with acute gastroenteritis (AGE).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is generally recommended that oral rehydration should be used as first-line therapy to
      treat or prevent dehydration in children with acute gastroenteritis (AGE). Despite the proven
      efficacy of oral rehydration therapy it remains underused. The main reason for this is that
      an ORS neither reduces the frequency of bowel movements and fluid loss nor shortens the
      duration of illness, which decreases its acceptance. Moreover, unpalatability of regular ORS
      decrease its acceptance, especially in children with lower degrees of dehydration. Refusal to
      drink regular ORS interfere with compliance with the recommended treatment. Parents, but also
      health care professionals, demand safe, effective, inexpensive, but also well tolerated and
      accepted ORS for management of AGE.

      Recently, a new ORS (Hipp ORS 200 Apple) with improved taste has been developed, and is now
      frequently employed for the management of AGE. The proposed study will be the first
      double-blind randomized trial of this ORS. It will evaluate clinically meaningful benefits to
      be derived by children and caregivers from its use. If positive, this new ORS may become a
      routine recommendation for children with AGE.

      The objective of this study is to compare the tolerance, acceptance, efficacy and safety of a
      new ORS (Hipp ORS 200 Apple) with regular ORS recommended by ESPGHAN in children with AGE.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants That Were Successfully Rehydrated</measure>
    <time_frame>Proportion of successfully rehydrated at 24 hours</time_frame>
    <description>The following components are included in primary outcome:
resolution of signs of dehydration
adequate weight gain
production of urine output during the trial</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Unscheduled Intravenous Therapy</measure>
    <time_frame>24 hours</time_frame>
    <description>Need for intravenous therapy within 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vomiting</measure>
    <time_frame>24 hours</time_frame>
    <description>Vomiting starting or progressing in the first 24 hours of therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ORS Intake in ml</measure>
    <time_frame>24 hours</time_frame>
    <description>ORS intake in ml (in the first 24 hours, and total)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight Gain in Gram</measure>
    <time_frame>24 hours</time_frame>
    <description>Weight gain in gram (in the first 24 hours, and total)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Diarrhea (Hrs)</measure>
    <time_frame>7days</time_frame>
    <description>Time of diarrhea in hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return Visit to the Emergency Department</measure>
    <time_frame>1 week</time_frame>
    <description>Return visit to the emergency department within a week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization</measure>
    <time_frame>1 week</time_frame>
    <description>need for hospitalization within a week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>24 hours</time_frame>
    <description>any adverse event, providing a description if related or not related to study intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ORS Intake at 4 h</measure>
    <time_frame>4 hrs</time_frame>
    <description>% of prescribed ORS that was consumed during first 4 hours</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">147</enrollment>
  <condition>Diarrhea</condition>
  <arm_group>
    <arm_group_label>Hipp ORS Apple 200</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral rehydration solution Hipp ORS 200 Apple</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESPGHAN ORS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ESPGHAN oral rehydration solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>oral rehydration solution Hipp ORS Apple 200</intervention_name>
    <description>Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
    <arm_group_label>Hipp ORS Apple 200</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ESPGHAN ORS</intervention_name>
    <description>Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
    <arm_group_label>ESPGHAN ORS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children age 4 to 48 months

          -  diarrhoea defined as the passage of three or more loose or watery stools per day for
             &gt;1 but &lt;5 days

          -  mild (3%) or moderate dehydration (3-9%) according to the World Health Organization
             criteria (Table 1)

          -  informed consent signed by at least one parent / caregiver

        Exclusion Criteria:

          -  diarrhea for &lt;1 or &gt;5 days

          -  severe dehydration (&gt;9%)

          -  recent history of diarrhea indicated either by parent/guardian or hospital case notes

          -  underlying chronic gastrointestinal disease (i.e., celiac disease, cow's milk protein
             intolerance)

          -  breastfeeding &gt;50%

          -  under nutrition (weight/height ratio below the fifth percentile)

          -  systemic infections

          -  immune defects or immunosuppressive treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Months</minimum_age>
    <maximum_age>48 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hania Szajewska, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Medical University of Warsaw, Poland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Peadiatrics, The Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <zip>01-183</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Guarino A, Albano F, Ashkenazi S, Gendrel D, Hoekstra JH, Shamir R, Szajewska H; ESPGHAN/ESPID Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe Expert Working Group. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: executive summary. J Pediatr Gastroenterol Nutr. 2008 May;46(5):619-21. doi: 10.1097/MPG.0b013e31816e219e.</citation>
    <PMID>18493225</PMID>
  </reference>
  <reference>
    <citation>Recommendations for composition of oral rehydration solutions for the children of Europe. Report of an ESPGAN Working Group. J Pediatr Gastroenterol Nutr. 1992 Jan;14(1):113-5.</citation>
    <PMID>1573500</PMID>
  </reference>
  <reference>
    <citation>Szajewska H, Hoekstra JH, Sandhu B; ESPGHAN Working Group on Acute Diarrhoea. Management of acute gastroenteritis in Europe and the impact of the new recommendations: a multicenter study. The Working Group on acute Diarrhoea of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2000 May;30(5):522-7.</citation>
    <PMID>10817282</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2011</study_first_submitted>
  <study_first_submitted_qc>November 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2011</study_first_posted>
  <results_first_submitted>November 20, 2013</results_first_submitted>
  <results_first_submitted_qc>February 14, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 1, 2014</results_first_posted>
  <last_update_submitted>February 14, 2014</last_update_submitted>
  <last_update_submitted_qc>February 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diarrhea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Gastroenteritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This was a double blind, randomized controlled trial carried out in the emergency departments of 2 pediatric hospitals in Poland (The Medical University of Warsaw and St Hedvig of Silesia Hospital, Trzebnica).</recruitment_details>
      <pre_assignment_details>Of the 147 children who underwent randomization, 72 were assigned to the experimental group and 75 were assigned to the control group. 17 children discontinued the study and eventually were lost to follow-up. The reason for lost to follow-up: parents refusal (N=2), not attend to scheduled visit (N=12), diarry lost (N=2), randomization error (N=1).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ESPGHAN ORS</title>
          <description>ESPGHAN oral rehydration solution
ESPGHAN ORS : Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
        </group>
        <group group_id="P2">
          <title>Hipp ORS Apple 200</title>
          <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200 : Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="72"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="67"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ESPGHAN ORS</title>
          <description>ESPGHAN oral rehydration solution
ESPGHAN ORS : Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
        </group>
        <group group_id="B2">
          <title>Hipp ORS Apple 200</title>
          <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200 : Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="75"/>
            <count group_id="B2" value="72"/>
            <count group_id="B3" value="147"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="147"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.8" spread="0.5"/>
                    <measurement group_id="B2" value="1.6" spread="0.8"/>
                    <measurement group_id="B3" value="1.75" spread="0.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Poland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="147"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants That Were Successfully Rehydrated</title>
        <description>The following components are included in primary outcome:
resolution of signs of dehydration
adequate weight gain
production of urine output during the trial</description>
        <time_frame>Proportion of successfully rehydrated at 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ESPGHAN ORS</title>
            <description>ESPGHAN oral rehydration solution
ESPGHAN ORS : Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
          <group group_id="O2">
            <title>Hipp ORS Apple 200</title>
            <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200 : Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants That Were Successfully Rehydrated</title>
          <description>The following components are included in primary outcome:
resolution of signs of dehydration
adequate weight gain
production of urine output during the trial</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="67"/>
                <count group_id="O2" value="63"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The differences between study groups were considered significant when the p value was &lt;0.05 or when the 95% CI for RD or MD did not include 0 (equivalent to p &lt; 0.05).</non_inferiority_desc>
            <p_value>0.28</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Unscheduled Intravenous Therapy</title>
        <description>Need for intravenous therapy within 24 hours</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hipp ORS Apple 200</title>
            <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
          <group group_id="O2">
            <title>ESPGHAN ORS</title>
            <description>ESPGHAN oral rehydration solution
ESPGHAN ORS: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
        </group_list>
        <measure>
          <title>Unscheduled Intravenous Therapy</title>
          <description>Need for intravenous therapy within 24 hours</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vomiting</title>
        <description>Vomiting starting or progressing in the first 24 hours of therapy</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hipp ORS Apple 200</title>
            <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
          <group group_id="O2">
            <title>ESPGHAN ORS</title>
            <description>ESPGHAN oral rehydration solution
ESPGHAN ORS: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
        </group_list>
        <measure>
          <title>Vomiting</title>
          <description>Vomiting starting or progressing in the first 24 hours of therapy</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ORS Intake in ml</title>
        <description>ORS intake in ml (in the first 24 hours, and total)</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hipp ORS Apple 200</title>
            <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
          <group group_id="O2">
            <title>ESPGHAN ORS</title>
            <description>ESPGHAN oral rehydration solution
ESPGHAN ORS: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
        </group_list>
        <measure>
          <title>ORS Intake in ml</title>
          <description>ORS intake in ml (in the first 24 hours, and total)</description>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.4" spread="36.6"/>
                    <measurement group_id="O2" value="50.2" spread="34.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Weight Gain in Gram</title>
        <description>Weight gain in gram (in the first 24 hours, and total)</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hipp ORS Apple 200</title>
            <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
          <group group_id="O2">
            <title>ESPGHAN ORS</title>
            <description>ESPGHAN oral rehydration solution
ESPGHAN ORS: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
        </group_list>
        <measure>
          <title>Weight Gain in Gram</title>
          <description>Weight gain in gram (in the first 24 hours, and total)</description>
          <units>gram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" spread="198"/>
                    <measurement group_id="O2" value="123" spread="167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Diarrhea (Hrs)</title>
        <description>Time of diarrhea in hours</description>
        <time_frame>7days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hipp ORS Apple 200</title>
            <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
          <group group_id="O2">
            <title>ESPGHAN ORS</title>
            <description>ESPGHAN oral rehydration solution
ESPGHAN ORS: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Diarrhea (Hrs)</title>
          <description>Time of diarrhea in hours</description>
          <units>hrs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.1" spread="42.6"/>
                    <measurement group_id="O2" value="61.9" spread="38.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Return Visit to the Emergency Department</title>
        <description>Return visit to the emergency department within a week</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hipp ORS Apple 200</title>
            <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
          <group group_id="O2">
            <title>ESPGHAN ORS</title>
            <description>ESPGHAN oral rehydration solution
ESPGHAN ORS: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
        </group_list>
        <measure>
          <title>Return Visit to the Emergency Department</title>
          <description>Return visit to the emergency department within a week</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalization</title>
        <description>need for hospitalization within a week</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hipp ORS Apple 200</title>
            <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
          <group group_id="O2">
            <title>ESPGHAN ORS</title>
            <description>ESPGHAN oral rehydration solution
ESPGHAN ORS: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalization</title>
          <description>need for hospitalization within a week</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Events</title>
        <description>any adverse event, providing a description if related or not related to study intervention</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hipp ORS Apple 200</title>
            <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
          <group group_id="O2">
            <title>ESPGHAN ORS</title>
            <description>ESPGHAN oral rehydration solution
ESPGHAN ORS: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Events</title>
          <description>any adverse event, providing a description if related or not related to study intervention</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ORS Intake at 4 h</title>
        <description>% of prescribed ORS that was consumed during first 4 hours</description>
        <time_frame>4 hrs</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ESPGHAN ORS</title>
            <description>ESPGHAN oral rehydration solution
ESPGHAN ORS : Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
          <group group_id="O2">
            <title>Hipp ORS Apple 200</title>
            <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200 : Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
          </group>
        </group_list>
        <measure>
          <title>ORS Intake at 4 h</title>
          <description>% of prescribed ORS that was consumed during first 4 hours</description>
          <units>percentage of prescribed ORS</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="67"/>
                <count group_id="O2" value="63"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.6" spread="21"/>
                    <measurement group_id="O2" value="33.2" spread="24.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>7 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Hipp ORS Apple 200</title>
          <description>oral rehydration solution Hipp ORS 200 Apple
oral rehydration solution Hipp ORS Apple 200: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
        </group>
        <group group_id="E2">
          <title>ESPGHAN ORS</title>
          <description>ESPGHAN oral rehydration solution
ESPGHAN ORS: Volume of the solution calculated by weight:
fast oral rehydration in 3-4 hours by mouth
ORS given for ongoing losses until diarrhea stops (maintenance phase)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="67"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="67"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Potential limitations included lack of perfect blinding. Because of technological reasons, it was not feasible to produce study products that were identical in colour, smell and taste.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Hanna Szajewska, Malgorzata Piescik-Lech</name_or_title>
      <organization>The Medical University of Warsaw</organization>
      <phone>+48-22-45-23-309</phone>
      <email>hania@ipgate.pl</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

